• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CHA₂DS₂-VASc评分在急性冠脉综合征患者中的预测作用及在CHA₂DS₂-VASc评分中加入整体纵向应变的价值。

Predictive role of CHA₂DS₂-VASc score in acute coronary syndrome patients and value of adding global longitudinal strain to CHA₂DS₂-VASc score.

作者信息

Allam Hager, Mostafa Shaimaa, Abd Khalek El-Sayed, Abdalla Sara

机构信息

Cardiology Department, Faculty of Medicine, Benha University, Benha, Egypt.

Cardiology Department, Faculty of Medicine, Benha University, Benha, Egypt.

出版信息

Indian Heart J. 2025 Jan-Feb;77(1):1-6. doi: 10.1016/j.ihj.2024.12.001. Epub 2024 Dec 21.

DOI:10.1016/j.ihj.2024.12.001
PMID:39716686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11977136/
Abstract

BACKGROUND

Future clinical management would be improved by accurate and early identification of ACS patients at high CV risk. In non-valvular atrial fibrillation patients, the prognostic risk of thromboembolism has been evaluated using CHA₂DS₂-VASc scores. It has recently been shown to assess the severity of CAD and foresee patient outcomes. Also, LV global longitudinal strain is an independent predictor of outcome. Our study aimed to determine the added value of LV longitudinal strain (GLS) to CHA₂DS₂-VASc in predicting the outcome and severity of CAD in patients with acute coronary syndrome (ACS).

METHODS

A total of 577 patients with primary diagnosis of ACS were included between January and July 2021. All patients had evaluations based on history, clinical examination, 12-lead ECG, TTE, and coronary angiography. Six months follow-up had been provided to all patients.

RESULTS

Syntax score was significantly higher among patients with high-risk CHA₂DS₂-VASc score (30.5 ± 6.1 vs. 17.34 ± 8.7 vs. 11.11 ± 8.2), p-value <0. 001. GLS was significantly lower among high SYNTAX score (-10.97 ± 2.68 vs. -12.61 ± 3.46 vs. -17.81 ± 2.89), p-value = 0.0001. There was a significant negative correlation between the CHA₂DS₂-VASc score and GLS. Moreover, adding GLS to CHA₂DS₂-VASc score significantly improved overall accuracy for the prediction of outcome and severity of CAD in ACS patients.

CONCLUSIONS

CHA₂DS₂-VASc score is an easy and simple parameter that can be used in predicting the severity of CAD & adverse clinical outcome in ACS patients and adding GLS to the CHA₂DS₂-VASc score significantly improved overall accuracy.

摘要

背景

准确且早期识别具有高心血管风险的急性冠状动脉综合征(ACS)患者,将有助于改善未来的临床管理。在非瓣膜性心房颤动患者中,已使用CHA₂DS₂-VASc评分评估血栓栓塞的预后风险。最近研究表明,该评分可用于评估冠状动脉疾病(CAD)的严重程度并预测患者预后。此外,左心室整体纵向应变是预后的独立预测指标。我们的研究旨在确定左心室纵向应变(GLS)对CHA₂DS₂-VASc评分在预测急性冠状动脉综合征(ACS)患者CAD预后和严重程度方面的附加价值。

方法

纳入2021年1月至7月期间初次诊断为ACS的577例患者。所有患者均根据病史、临床检查、12导联心电图、经胸超声心动图(TTE)和冠状动脉造影进行评估。所有患者均接受了6个月的随访。

结果

CHA₂DS₂-VASc高危评分患者的Syntax评分显著更高(分别为30.5 ± 6.1、17.34 ± 8.7和11.11 ± 8.2),p值<0.001。Syntax高分患者的GLS显著更低(分别为-10.97 ± 2.68、-12.61 ± 3.46和-17.81 ± 2.89),p值 = 0.0001。CHA₂DS₂-VASc评分与GLS之间存在显著负相关。此外,将GLS添加到CHA₂DS₂-VASc评分中可显著提高预测ACS患者CAD预后和严重程度的总体准确性。

结论

CHA₂DS₂-VASc评分是一个简单易用的参数,可用于预测ACS患者CAD的严重程度和不良临床结局,将GLS添加到CHA₂DS₂-VASc评分中可显著提高总体准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2031/11977136/f3fedce00bc1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2031/11977136/191402ae62f4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2031/11977136/f3fedce00bc1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2031/11977136/191402ae62f4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2031/11977136/f3fedce00bc1/gr2.jpg

相似文献

1
Predictive role of CHA₂DS₂-VASc score in acute coronary syndrome patients and value of adding global longitudinal strain to CHA₂DS₂-VASc score.CHA₂DS₂-VASc评分在急性冠脉综合征患者中的预测作用及在CHA₂DS₂-VASc评分中加入整体纵向应变的价值。
Indian Heart J. 2025 Jan-Feb;77(1):1-6. doi: 10.1016/j.ihj.2024.12.001. Epub 2024 Dec 21.
2
Usefulness of layer-specific strain for identifying complex CAD and predicting the severity of coronary lesions in patients with non-ST-segment elevation acute coronary syndrome: Compared with Syntax score.非ST段抬高型急性冠状动脉综合征患者中,层特异性应变在识别复杂冠状动脉疾病和预测冠状动脉病变严重程度方面的效用:与Syntax评分的比较
Int J Cardiol. 2016 Nov 15;223:1045-1052. doi: 10.1016/j.ijcard.2016.08.277. Epub 2016 Aug 18.
3
Coronary artery disease severity and risk stratification of patients with non ST-elevation acute coronary syndrome using CHADS-VASc-HSF score.采用 CHADS-VASc-HSF 评分评估非 ST 段抬高型急性冠脉综合征患者的冠状动脉疾病严重程度和风险分层。
BMC Cardiovasc Disord. 2024 May 21;24(1):263. doi: 10.1186/s12872-024-03929-5.
4
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.尽管接受了口服抗凝治疗,但CHA2DS2-VASc评分对房颤高危卒中患者的预测价值。
Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. Epub 2012 May 18.
5
Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation.多民族美国人群中非瓣膜性心房颤动患者 CHADS2 和 CHA2DS2-VASc 评分与经食管超声心动图血栓栓塞危险因素的相关性。
J Am Soc Echocardiogr. 2013 Feb;26(2):175-84. doi: 10.1016/j.echo.2012.11.002. Epub 2012 Dec 17.
6
CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.非ST段抬高型急性冠状动脉综合征患者的CHA2DS2-VASc-HS评分:评估冠状动脉疾病的严重程度和复杂性,并与其他评分系统比较以预测院内主要不良心血管事件
Anatol J Cardiol. 2016 Oct;16(10):742-748. doi: 10.14744/AnatolJCardiol.2015.6593. Epub 2016 Mar 23.
7
Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores.根据 CHADS2 和 CHA2 DS2 -VASc 评分的非瓣膜性心房颤动患者的卒中机制。
Eur J Neurol. 2012 Mar;19(3):473-9. doi: 10.1111/j.1468-1331.2011.03547.x. Epub 2011 Oct 4.
8
Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.可靠识别最初诊断为“孤立”心房颤动患者中的“真正低”血栓栓塞风险:贝尔格莱德心房颤动研究。
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):319-26. doi: 10.1161/CIRCEP.111.966713. Epub 2012 Feb 8.
9
Clinical Application of CHADS-VASc versus GRACE Scores for Assessing the Risk of Long-term Ischemic Events in Atrial Fibrillation and Acute Coronary Syndrome or PCI.CHADS-VASc评分与GRACE评分在评估心房颤动合并急性冠状动脉综合征或经皮冠状动脉介入治疗患者长期缺血事件风险中的临床应用
Rev Cardiovasc Med. 2022 May 11;23(5):168. doi: 10.31083/j.rcm2305168. eCollection 2022 May.
10
Relationship between CHADS-VASc score, coronary artery disease severity, residual platelet reactivity and long-term clinical outcomes in patients with acute coronary syndrome.急性冠状动脉综合征患者 CHADS-VASc 评分、冠状动脉疾病严重程度、残余血小板反应性与长期临床结局的关系。
Int J Cardiol. 2018 Jul 1;262:9-13. doi: 10.1016/j.ijcard.2018.03.086. Epub 2018 Mar 20.

本文引用的文献

1
The utility of SYNTAX score predictability by electrocardiogram parameters in patients with unstable angina.心电图参数预测不稳定型心绞痛患者 SYNTAX 评分的效用。
BMC Cardiovasc Disord. 2022 Jan 12;22(1):8. doi: 10.1186/s12872-022-02455-6.
2
Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.CHA2DS2-VASc 评分对非心房颤动的非 ST 段抬高型心肌梗死患者高 SYNTAX 评分和住院死亡率的预测价值。
Anatol J Cardiol. 2021 Nov;25(11):789-795. doi: 10.5152/AnatolJCardiol.2021.03982.
3
Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review.
流行病学与冠状动脉疾病和急性冠状动脉综合征的严重程度:叙事性综述。
J Epidemiol Glob Health. 2021 Jun;11(2):169-177. doi: 10.2991/jegh.k.201217.001. Epub 2021 Jan 7.
4
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
5
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Eur Heart J. 2021 Apr 7;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.
6
Usefulness of the CHADS-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.CHADS-VASc 评分在经皮冠状动脉介入治疗的无房颤急性冠状动脉综合征患者中预测不良结局的价值。
Am J Cardiol. 2019 Aug 15;124(4):476-484. doi: 10.1016/j.amjcard.2019.05.036. Epub 2019 May 29.
7
CHADS-VASc and R-CHADS-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction.CHADS-VASc评分和R-CHADS-VASc评分可预测心肌梗死患者的住院期间及出院后的预后。
Postepy Kardiol Interwencyjnej. 2018;14(4):391-398. doi: 10.5114/aic.2018.79869. Epub 2018 Dec 11.
8
Epidemiology of cardiovascular disease in China: current features and implications.中国心血管疾病的流行病学:现状特征及影响。
Nat Rev Cardiol. 2019 Apr;16(4):203-212. doi: 10.1038/s41569-018-0119-4.
9
Fourth Universal Definition of Myocardial Infarction (2018).心肌梗死的第四次全球定义(2018年)。
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25.
10
Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart Failure.全球应变率预测急性心力衰竭患者的死亡率。
J Am Coll Cardiol. 2018 May 8;71(18):1947-1957. doi: 10.1016/j.jacc.2018.02.064.